Switch to:
More From Other Websites
NeoStem Announces Licensing of Patent Portfolio From The Rockefeller University Expanding Its Cancer... Sep 11 2014
NeoStem and PCT, A NeoStem Company, to Present at Multiple September Conferences Sep 09 2014
NEOSTEM, INC. Files SEC form 8-K, Regulation FD Disclosure Sep 08 2014
NeoStem Letter to Shareholders Sep 08 2014
NeoStem, Inc. - "Seizing an Opportunity to Fight Cancer" Sep 04 2014
NeoStem to Present at the Swedish-American Life Science Summit 2014 Aug 20 2014
NEOSTEM, INC. Financials Aug 19 2014
NEOSTEM, INC. Files SEC form 8-K, Results of Operations and Financial Condition Aug 07 2014
NeoStem Announces Second Quarter 2014 Financial Results and Provides Business Update Aug 07 2014
NEOSTEM, INC. Files SEC form 10-Q, Quarterly Report Aug 07 2014
Increase Company Value Through Mergers, Acquisitions Jul 14 2014
NeoStem Awarded 2014 Cell Therapeutics Technology Leadership Award from Frost & Sullivan Jul 14 2014
NeoStem, Inc. – "Insider Buying" Jul 08 2014
RedChip Announces Schedule for Its July 16-17 Global Online CEO Conference Jul 08 2014
NEOSTEM, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Jul 08 2014
NeoStem Appoints Steven M. Klosk to Board of Directors Jul 08 2014
NeoStem's Cancer Immunotherapy Experts to Present at Novel Cancer Therapeutics Summit 2014 Jun 30 2014
NeoStem, Inc. "Cancer Treatment that Doesn't Make You Sick" Jun 25 2014
NeoStem Set to Join Multiple Russell Indexes Jun 23 2014
NeoStem presents results for Phase 1 study of autologous Treg immunotherapy Jun 16 2014


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK